Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ion Beratis

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
Parkinsonism & Related Disorders|July 3, 2020
DaTSCAN (123I-FP-CIT SPECT) imaging in early versus mid and late onset Parkinson's disease: Longitudinal data from the PPMI studyChristos Koros, Athina-Maria Simitsi, Andreas Prentakis, et al.
Biomedicines|July 29, 2025
Prospective Neuropsychological and Plasma Biomarker Changes in Treatment-Naïve People Living with HIV After Antiretroviral Treatment InitiationCharalampos D Moschopoulos, Evangelia Stanitsa, Konstantinos Protopapas, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|October 6, 2018
123I-FP-CIT SPECT [(123) I-2β-carbomethoxy-3β-(4-iodophenyl)-N-(3-fluoropropyl) nortropane single photon emission computed tomography] Imaging in a p.A53T α-synuclein Parkinson's disease cohort versus Parkinson's diseaseChristos Koros, Athina Simitsi, Andreas Prentakis, et al.
Journal of Neurology|February 11, 2025
Motor and nonmotor features of p.A53T alpha-synuclein PD vs idiopathic PD: longitudinal data from the PPMI studyAthina Maria Simitsi, Evangelos Sfikas, Christos Koros, et al.
Geriatrics (Basel, Switzerland)|January 17, 2023
<i>APOE</i> Allele Frequency in Southern Greece: Exploring the Role of Geographical Gradient in the Greek PopulationVasiliki Papastefanopoulou, Evangelia Stanitsa, Christos Koros, et al.
Parkinsonism & Related Disorders|May 1, 2022
Asymptomatic carriers of the p.A53T SNCA mutation: Data from the PPMI studyAthina Maria Simitsi, Christos Koros, Maria Stamelou, et al.
Journal of Clinical Medicine|March 14, 2026
Association of Impulse Control Disorders with Cognitive Performance and Frontal Dysfunction in Patients with Parkinson's DiseaseMaria Bougia, Aristeidis Papadaniil, Evangelia Smaragdaki, et al.
Journal of Parkinson'S Disease|March 17, 2020
Serum Uric Acid Level as a Biomarker in Idiopathic and Genetic (p.A53T Alpha-Synuclein Carriers) Parkinson's Disease: Data from the PPMI StudyChristos Koros, Athina-Maria Simitsi, Dimitra Papadimitriou, et al.
Parkinsonism & Related Disorders|August 23, 2021
Apathy: An underestimated feature in GBA and LRRK2 non-manifesting mutation carriersIoanna Pachi, Christos Koros, Athina M Simitsi, et al.
Journal of Parkinson'S Disease|March 8, 2021
Serum Uric Acid in LRRK2 Related Parkinson's Disease: Longitudinal Data from the PPMI StudyAnastasia Bougea, Christos Koros, Nikolaos Papagiannakis, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Parkinsonism & Related Disorders|July 3, 2020
DaTSCAN (123I-FP-CIT SPECT) imaging in early versus mid and late onset Parkinson's disease: Longitudinal data from the PPMI studyChristos Koros, Athina-Maria Simitsi, Andreas Prentakis, et al.
Biomedicines|July 29, 2025
Prospective Neuropsychological and Plasma Biomarker Changes in Treatment-Naïve People Living with HIV After Antiretroviral Treatment InitiationCharalampos D Moschopoulos, Evangelia Stanitsa, Konstantinos Protopapas, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|October 6, 2018
123I-FP-CIT SPECT [(123) I-2β-carbomethoxy-3β-(4-iodophenyl)-N-(3-fluoropropyl) nortropane single photon emission computed tomography] Imaging in a p.A53T α-synuclein Parkinson's disease cohort versus Parkinson's diseaseChristos Koros, Athina Simitsi, Andreas Prentakis, et al.
Journal of Neurology|February 11, 2025
Motor and nonmotor features of p.A53T alpha-synuclein PD vs idiopathic PD: longitudinal data from the PPMI studyAthina Maria Simitsi, Evangelos Sfikas, Christos Koros, et al.
Geriatrics (Basel, Switzerland)|January 17, 2023
<i>APOE</i> Allele Frequency in Southern Greece: Exploring the Role of Geographical Gradient in the Greek PopulationVasiliki Papastefanopoulou, Evangelia Stanitsa, Christos Koros, et al.
Parkinsonism & Related Disorders|May 1, 2022
Asymptomatic carriers of the p.A53T SNCA mutation: Data from the PPMI studyAthina Maria Simitsi, Christos Koros, Maria Stamelou, et al.
Journal of Clinical Medicine|March 14, 2026
Association of Impulse Control Disorders with Cognitive Performance and Frontal Dysfunction in Patients with Parkinson's DiseaseMaria Bougia, Aristeidis Papadaniil, Evangelia Smaragdaki, et al.
Journal of Parkinson'S Disease|March 17, 2020
Serum Uric Acid Level as a Biomarker in Idiopathic and Genetic (p.A53T Alpha-Synuclein Carriers) Parkinson's Disease: Data from the PPMI StudyChristos Koros, Athina-Maria Simitsi, Dimitra Papadimitriou, et al.
Parkinsonism & Related Disorders|August 23, 2021
Apathy: An underestimated feature in GBA and LRRK2 non-manifesting mutation carriersIoanna Pachi, Christos Koros, Athina M Simitsi, et al.
Journal of Parkinson'S Disease|March 8, 2021
Serum Uric Acid in LRRK2 Related Parkinson's Disease: Longitudinal Data from the PPMI StudyAnastasia Bougea, Christos Koros, Nikolaos Papagiannakis, et al.
Pageof 3